Cargando…

Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies

An effective malaria vaccine remains a global health priority and vaccine immunogens which prevent transmission of the parasite will have important roles in multi-component vaccines. One of the most promising candidates for inclusion in a transmission-blocking malaria vaccine is the gamete surface p...

Descripción completa

Detalles Bibliográficos
Autores principales: Ko, Kuang-Ting, Lennartz, Frank, Mekhaiel, David, Guloglu, Bora, Marini, Arianna, Deuker, Danielle J., Long, Carole A., Jore, Matthijs M., Miura, Kazutoyo, Biswas, Sumi, Higgins, Matthew K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509318/
https://www.ncbi.nlm.nih.gov/pubmed/36153317
http://dx.doi.org/10.1038/s41467-022-33379-6
_version_ 1784797212628221952
author Ko, Kuang-Ting
Lennartz, Frank
Mekhaiel, David
Guloglu, Bora
Marini, Arianna
Deuker, Danielle J.
Long, Carole A.
Jore, Matthijs M.
Miura, Kazutoyo
Biswas, Sumi
Higgins, Matthew K.
author_facet Ko, Kuang-Ting
Lennartz, Frank
Mekhaiel, David
Guloglu, Bora
Marini, Arianna
Deuker, Danielle J.
Long, Carole A.
Jore, Matthijs M.
Miura, Kazutoyo
Biswas, Sumi
Higgins, Matthew K.
author_sort Ko, Kuang-Ting
collection PubMed
description An effective malaria vaccine remains a global health priority and vaccine immunogens which prevent transmission of the parasite will have important roles in multi-component vaccines. One of the most promising candidates for inclusion in a transmission-blocking malaria vaccine is the gamete surface protein Pfs48/45, which is essential for development of the parasite in the mosquito midgut. Indeed, antibodies which bind Pfs48/45 can prevent transmission if ingested with the parasite as part of the mosquito bloodmeal. Here we present the structure of full-length Pfs48/45, showing its three domains to form a dynamic, planar, triangular arrangement. We reveal where transmission-blocking and non-blocking antibodies bind on Pfs48/45. Finally, we demonstrate that antibodies which bind across this molecule can be transmission-blocking. These studies will guide the development of future Pfs48/45-based vaccine immunogens.
format Online
Article
Text
id pubmed-9509318
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-95093182022-09-26 Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies Ko, Kuang-Ting Lennartz, Frank Mekhaiel, David Guloglu, Bora Marini, Arianna Deuker, Danielle J. Long, Carole A. Jore, Matthijs M. Miura, Kazutoyo Biswas, Sumi Higgins, Matthew K. Nat Commun Article An effective malaria vaccine remains a global health priority and vaccine immunogens which prevent transmission of the parasite will have important roles in multi-component vaccines. One of the most promising candidates for inclusion in a transmission-blocking malaria vaccine is the gamete surface protein Pfs48/45, which is essential for development of the parasite in the mosquito midgut. Indeed, antibodies which bind Pfs48/45 can prevent transmission if ingested with the parasite as part of the mosquito bloodmeal. Here we present the structure of full-length Pfs48/45, showing its three domains to form a dynamic, planar, triangular arrangement. We reveal where transmission-blocking and non-blocking antibodies bind on Pfs48/45. Finally, we demonstrate that antibodies which bind across this molecule can be transmission-blocking. These studies will guide the development of future Pfs48/45-based vaccine immunogens. Nature Publishing Group UK 2022-09-24 /pmc/articles/PMC9509318/ /pubmed/36153317 http://dx.doi.org/10.1038/s41467-022-33379-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Ko, Kuang-Ting
Lennartz, Frank
Mekhaiel, David
Guloglu, Bora
Marini, Arianna
Deuker, Danielle J.
Long, Carole A.
Jore, Matthijs M.
Miura, Kazutoyo
Biswas, Sumi
Higgins, Matthew K.
Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies
title Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies
title_full Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies
title_fullStr Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies
title_full_unstemmed Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies
title_short Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies
title_sort structure of the malaria vaccine candidate pfs48/45 and its recognition by transmission blocking antibodies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509318/
https://www.ncbi.nlm.nih.gov/pubmed/36153317
http://dx.doi.org/10.1038/s41467-022-33379-6
work_keys_str_mv AT kokuangting structureofthemalariavaccinecandidatepfs4845anditsrecognitionbytransmissionblockingantibodies
AT lennartzfrank structureofthemalariavaccinecandidatepfs4845anditsrecognitionbytransmissionblockingantibodies
AT mekhaieldavid structureofthemalariavaccinecandidatepfs4845anditsrecognitionbytransmissionblockingantibodies
AT guloglubora structureofthemalariavaccinecandidatepfs4845anditsrecognitionbytransmissionblockingantibodies
AT mariniarianna structureofthemalariavaccinecandidatepfs4845anditsrecognitionbytransmissionblockingantibodies
AT deukerdaniellej structureofthemalariavaccinecandidatepfs4845anditsrecognitionbytransmissionblockingantibodies
AT longcarolea structureofthemalariavaccinecandidatepfs4845anditsrecognitionbytransmissionblockingantibodies
AT jorematthijsm structureofthemalariavaccinecandidatepfs4845anditsrecognitionbytransmissionblockingantibodies
AT miurakazutoyo structureofthemalariavaccinecandidatepfs4845anditsrecognitionbytransmissionblockingantibodies
AT biswassumi structureofthemalariavaccinecandidatepfs4845anditsrecognitionbytransmissionblockingantibodies
AT higginsmatthewk structureofthemalariavaccinecandidatepfs4845anditsrecognitionbytransmissionblockingantibodies